Information Provided By: 
Fly News Breaks for January 31, 2018
ILMN
Jan 31, 2018 | 05:53 EDT
Citi analyst Daniel Arias raised his price target for Illumina to $260 saying robust sequencing consumables demand and solid instrument contributions drove the Q4 revenue beat. With no change to guidance and a positive tone, Illumina probably trades flat-to-up today, as management did little to dampen the enthusiasm coming out of JPMorgan's healthcare conference, Arias tells investors in a post-earnings research note. The analyst keeps a Neutral rating on Illumina.
News For ILMN From the Last 2 Days
There are no results for your query ILMN
